Evidence supporting a direct suppressive effect of growth hormone on serum IGFBP-1 levels. Experimental studies in normal, obese and GH-deficient adults

Growth Hormone and IGF Research

Volumn 9, Issue 1, 1999, Pages 52-60

  Fisker, Sanne ^a   Vahl, Nina ^a   Børglum, Jens ^a   Richelsen, Bjørn ^a   Christiansen, Jens Sandahl ^a   Jørgensen, Jens Otto Lunde ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Growth hormone; IGFBP 1

Indexed keywords

GROWTH HORMONE; INSULIN; SOMATOMEDIN BINDING PROTEIN 1; SOMATOSTATIN;

ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE DEFICIENCY; HORMONAL THERAPY; HUMAN; INSULIN BLOOD LEVEL; LOW CALORY DIET; MALE; OBESITY; PRIORITY JOURNAL; REGULATORY MECHANISM;

EID: 0033081267     PISSN: 10966374     EISSN: None     Source Type: Journal    
DOI: 10.1054/ghir.1998.0087     Document Type: Article

References (33)

1. Bar R. S., Boes M., Clemmons D. R. Insulin differentially alters transcapillary movement of intravascular IGFBP-1, IGFBP-2 and endothelial cell IGF-binding proteins in the rat heart. Endocrinology. 127:1990;497-499.
2. Bar R. S., Clemmons D. R., Boes M. Transcapillary permeability and subendothelial distribution of endothelial and amniotic fluid (IGFBP-1) IGF-binding proteins in the rat heart. Endocrinology. 127:1990;1078-1082.
3. Lee P. D., Conover C. A., Powell D. R. Regulation and function of insulin-like growth factor-binding protein-1. Proc Soc Exp Biol Med. 204:1993;4-29.
4. Hall K., Brismar K., Grissom F., Lindgren B., Povoa G. IGFBP-1. Production and control mechanisms. Acta Endocrinol Copenh. 124 (Suppl. 2):1991;48-54.
5. Hilding A., Brismar K., Degerblad M., Thoren M., Hall K. Altered relation between circulating levels of insulin-like growth factor-binding protein-1 and insulin in growth hormone-deficient patients and insulin-dependent diabetic patients compared to that in healthy subjects. J Clin Endocrinol Metab. 80:1995;2646-2652.
6. Conover C. A., Lee P. D., Kanaley J. A., Clarkson J. T., Jensen M. D. Insulin regulation of insulin-like growth factor binding protein-1 in obese and nonobese humans. J Clin Endocrinol Metab. 74:1992;1355-1360.
7. Cotterill A. M., Cowell C. T., Baxter R. C., McNeil D., Silinik M. Regulation of the growth hormone-independent growth factor-binding protein in children. J Clin Endocrinol Metab. 67:1988;882-887.
8. Busby W. H., Snyder D. K., Clemmons D. R. Radioimmunoassay of a 26,000-Dalton plasma insulin-like growth factor-binding protein: control by nutritional variables. J Clin Endocrinol Metab. 67:1988;1225-1230.
9. Lee P. D., Jensen M. D., Divertie G. D., Heiling V. J., Katz H. H., Conover C. A. Insulin-like growth factor-binding protein-1 response to insulin during suppression of endogenous insulin secretion. Metabolism. 42:1993;409-414.
10. Yeoh S. I., Baxter R. C. Metabolic regulation of the growth hormone independent insulin-like growth factor binding protein in human plasma. Acta Endocrinol. 119:1988;465-473.
11. Hilding A., Brismar K., Thoren M., Hall K. Glucagon stimulates insulin-like growth factor binding protein-1 secretion in healthy subjects, patients with pituitary insufficiency, and patients with insulin-dependent diabetes mellitus. J Clin Endocrinol Metab. 77:1993;1142-1147.
12. Conover C. A., Divertie G. D., Lee P. D. Cortisol increases plasma insulin-like growth factor binding protein-1 in humans. Acta Endocrinologica. 128:1993;140-143.
13. Baxter R. C., Cowell C. T. Diurnal rhythm of growth hormone-independent binding protein for insulin-like growth factors in human plasma. J Clin Endocrinol Metab. 65:1987;432-440.
14. Conover C. A., Butler P. C., Wang M., Rizza R. A., Lee P. D. Lack of growth hormone effect on insulin-associated suppression of insulin like growth factor binding protein 1 in humans. Diabetes. 39:1990;1251-1256.
15. Jorgensen J. O., Blum W. F., Horn N. Insulin-like growth factors (IGF) I and II and IGF binding proteins 1, 2 and 3 during low-dose growth hormone (GH) infusion and sequential euglycemic and hypoglycemic glucose clamps: studies in GH-deficient patients. Acta Endocrinol Copenh. 128:1993;513-520.
16. Jorgensen J. O., Moller N., Moller J., Weeke J., Blum W. F. Insulin-like growth factors (IGF)-I and -II and IGF binding protein-1, -2, and -3 in patients with acromegaly before and after adenomectomy. Metabolism. 43:1994;579-583.
17. Tapanainen J., Ronnberg L., Martikainen H., Reinila M., Koistinen R., Seppala M. Short and long term effects of growth hormone on circulating levels of insulin-like growth factor-I (IGF-I), IGF-binding protein-1, and insulin: a placebo-controlled study. J Clin Endocrinol Metab. 73:1991;71-74.
18. Lee P. D., Durham S. K., Martinez V., Vasconez O., Powell D. R., Guevara A. J. Kinetics of insulin-like growth factor (IGF) and IGF-binding protein responses to a single dose of growth hormone. J Clin Endocrinol Metab. 82:1997;2266-2274.
19. Rutanen E. M., Karkkainen T., Stenman U. H., Yki J. H. Ageing is associated with decreased suppression of insulin-like growth factor binding protein-1 by insulin. J Clin Endocrinol Metab. 77:1993;1152-1155.
20. Vahl N., Moller N., Lauritzen T., Christiansen J. S., Jorgensen J. O. Metabolic effects and pharmacokinetics of a growth hormone pulse in healthy adults: relation to age, sex, and body composition. J Clin Endocrinol Metab. 82:1997;3612-3618.
21. Orskov H., Thomsen H. G., Yde H. Wick chromatography for rapid and reliable immunoassay of insulin, glucagon and growth hormone. Nature. 219:1968;193-195.
22. Jorgensen J. O., Moller N., Bang P., Hall K. Preservation of inherent diurnal serum insulin-like growth factor binding protein 1 pattern during low dose GH infusion. Horm Metab Res. 24:1992;496-497.
23. Ezzat S., Ren S. G., Braunstein G. D., Melmed S. Octreotide stimulates insulin-like growth factor binding protein-1 (IGFBP-1) levels in acromegaly. J Clin Endocrinol Metab. 73:1991;441-443.
24. Ezzat S., Ren S. G., Braunstein G. D., Melmed S. Octreotide stimulates insulin-like growth factor-binding protein-1: a potential pituitary-independent mechanism for drug action. J Clin Endocrinol Metab. 75:1992;1459-1463.
25. Cotterill A. M., Holly J. M., Wass J. A. The regulation of insulin-like growth factor binding protein (IGFBP)-1 during prolonged fasting. Clin Endocrinol Oxf. 39:1993;357-362.
26. Holly J. M., Bibblecome R. A., Dunger D. B. Circadian variation of GH-independent IGF-binding protein in diabetes mellitus and its relationship to insulin. A new role for insulin? Clin Endocrinol. 29:1988;667-675.
27. Laron Z., Suikkari A. M., Klinger B. Growth hormone and insulin-like growth factor regulate insulin-like growth factor-binding protein-1 in Laron type dwarfism, growth hormone deficiency and constitutional short stature. Acta Endocrinol Copenh. 127:1992;351-358.
28. Jorgensen J. O., Pedersen S. B., Borglum J. Serum concentrations of insulin-like growth factors (IGFs), IGF binding proteins 1 and 3 and growth hormone binding protein in obese women and the effects of growth hormone administration: a double-blind, placebo-controlled study. Eur J Endocrinol. 133:1995;65-70.
29. Thissen J. P., Pucilowska J. B., Underwood L. E. Differential regulation of insulin-like growth factor I (IGF-I) and IGF binding protein-1 messenger ribonucleic acids by amino acid availability and growth hormone in rat hepatocyte primary culture. Endocrinology. 134:1994;1570-1576.
30. Villafuerte B. C., Goldstein s, Robertson D. G., Pao C. I., Murphy L. J., Phillips L. S. Molecular regulation of IGFBP-1 in hetatocyte primary culture. Diabetes. 41:1992;835-842.
31. Kobayashi S., Nogami H., Ikeda T. Growth hormone and nutrition interact to regulate expressions of kidney IGF-I and IGFBP mRNAs. Kidney Int. 48:1995;65-71.
32. Senevirante C., Luo J., Murphy L. J. Transcriptional regulation of rat insulin-like growth factor binding protein-1 expression by growth hormone. Mol Endocrinol. 4:1990;1199-1204.
33. Frystyk J., Skjaerbaek C., Dinesen B., Orskov H. Free insulin-like growth factors (IGF-I and IGF-II) in human serum. FEBS Lett. 348:1994;185-191.